Indicted Stimwave CEO Hit With $41M Civil Suit From SEC

By Hailey Konnath · December 19, 2023, 11:30 PM EST

The U.S. Securities and Exchange Commission on Tuesday accused the former CEO of bankrupt medical device maker Stimwave Technologies of defrauding investors out of roughly $41 million, filing a civil suit...

To view the full article, register now.